The IPEC-Americas Excipient Master File Guide

DeMerlis,Christopher;

The IPEC-Americas Excipient Master File Guide

June 1, 2002

By Christopher C. DeMerlis

News

Article

Pharmaceutical TechnologyPharmaceutical Technology-06-02-2002

Volume 26

Issue 6

A global drug master file system may pave the way for faster qualifications of new excipients and the industry's acceptance of their use in drug therapies.

External Link - article-20203.pdf

Articles in this issue

Excipient GMP Quality Standards: One is Enough

The IPEC-Americas Excipient Master File Guide

Technology Advances Anticounterfeiting Options

Calibration of Lyophilization Pressure Gauges

Drug Shortages Reveal GMP Concerns

Outsourcing Outlook

Optimizing Cross-Organizational Team Performance and Management

Screening for Counterfeit Drugs Using Near-Infrared Spectroscopy

Microencapsulation of Paracetamol by Various Emulsion Techniques Using Cellulose Acetate Phthalate

Building on Tradition: Integrating the Links of Expertise

Related Content

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Hikma Pharmaceuticals Invests $1 Billion to Expand US Generic Drug Capabilities, Releases Sustainability Report

Susan Haigney

June 30th 2025

Article

The company is expanding its US manufacturing and R&D capabilities with a $1 billion investment by 2030.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol

April 30th 2024

Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

3D Rendering of CAR - Chimeric Antigen Receptor Between T-Cell and Cancer Cell | Image Credit: © Alpha Tauri 3D - stock.adobe.com

Priothera Awarded €1.7M in Innovation Contest for Hematologic Malignancy Treatments

Patrick Lavery

June 26th 2025

Article

The company’s mocravimod, a novel oral S1P receptor, is being evaluated for its efficacy as an addition to CAR-T cell therapies.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024

Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.